Treatment Rechallenge With Checkpoint Inhibition in Patients With Mismatch Repair-Deficient Pancreatic Cancer After Planned Treatment Interruption

JCO Precis Oncol. 2020 Jun 30:4:PO.20.00052. doi: 10.1200/PO.20.00052. eCollection 2020.

Authors

Vaia Florou¹, Christopher Nevala-Plagemann¹, Kristin E Barber¹, Jenna N Mastroianni¹, Courtney C Cavalieri¹, Ignacio Garrido-Laguna¹

Affiliation

¹ Department of Internal Medicine, Division of Oncology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT.

No abstract available

Publication types

Case Reports

Grants and funding

P30 CA042014/CA/NCI NIH HHS/United States